Quanterix, Innovita win NMPA approvals for China IVD access

Quanterix and Innovita said China’s NMPA approved the Quanterix HD-X and SR-X instruments plus four neurology biomarker assay kits. The approvals expand access to SIMOA-based testing in China and support the companies’ commercialization arrangement.